“…Indeed, Cntnap2 is expressed in the MGE progenitors cells in humans (Satterstrom et al, 2020), and in future sub-pallial cholinergic and GABAergic neurons (Shi et al, 2021), suggesting that potential therapeutic interventions could be conducted from embryonic stages to rectify the altered developmental trajectory in ASD, but also a range of neurodevelopmental disorders such as schizophrenia, intellectual disability, dyslexia, epilepsy and attention-deficit hyperactivity disorder (Rodenas-Cuadrado et al, 2014;Poot, 2015). Disruption of cholinergic interneurons (CINs) in the striatum generate network and behavioral modifications significant to ASD (Rapanelli et al, 2017a;Caubit et al, 2022). Yet, how developing CINs are impacted in ASD has been poorly explored.…”